HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

6th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 20-22, 2025 | Orlando, Florida, USA

GAB 2025

Steven M Cohen

  1. Home
  2. Speakers
  3. Steven M Cohen
Steven M Cohen, Speaker at Psychiatry Conferences
Steven M Cohen
Akyso Therapeutics, United States

Biography:

Dr. Steven M. Cohen is Co-Founder and CEO of Drug Delivery Company, LLC DBA Akyso Therapeutics which is developing long-acting subcutaneous naltrexone and buprenorphine implants for opioid use disorder. Dr. Cohen has led multiple NIH-funded projects and clinical trials and has published extensively.

2025
Oral Presentation (In-Person)
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Watsapp